Home › Therapeutic areas › Neurology › Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder (3 companies)
Companies with an active program in Post-Traumatic Stress Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CMPS | COMPASS Pathways | Neurology | 1 | NDA Submitted | $1.22B | 3 |
| DFTX | Definium Therapeutics | Neurology | 1 | Phase 3 | $4.47B | 4 |
| NRXP | NRX Pharmaceuticals | Neurology Rare | 1 | Approved | $103M | 7 |
No companies match.